Regenxbio (RGNX) Cash & Equivalents Growth (5y) (2019 - 2025)
Regenxbio (RGNX) Cash & Equivalents Growth (5y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Regenxbio | 501.81 Mn | 271.74 Mn | 21.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -36.67% |
| Sep 30, 2025 | -8.80% |
| Jun 30, 2025 | -3.33% |
| Mar 31, 2025 | 13.39% |
| Dec 31, 2024 | -3.72% |
| Sep 30, 2024 | -6.59% |
| Jun 30, 2024 | 0.93% |
| Mar 31, 2024 | 15.13% |
| Dec 31, 2023 | -14.50% |
| Sep 30, 2023 | -17.92% |
| Jun 30, 2023 | -8.49% |
| Mar 31, 2023 | -0.50% |
| Dec 31, 2022 | 15.75% |
| Sep 30, 2022 | 14.63% |
| Jun 30, 2022 | 16.06% |
| Mar 31, 2022 | 18.52% |
| Dec 31, 2021 | 69.27% |
| Sep 30, 2021 | 52.04% |
| Jun 30, 2021 | 53.58% |
| Mar 31, 2021 | 52.35% |